ZECCHETTO, CAMILLA
 Distribuzione geografica
Continente #
EU - Europa 1.550
NA - Nord America 1.276
AS - Asia 916
SA - Sud America 158
AF - Africa 26
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.930
Nazione #
US - Stati Uniti d'America 1.245
RU - Federazione Russa 742
SG - Singapore 355
CN - Cina 311
IT - Italia 190
DE - Germania 134
BR - Brasile 132
GB - Regno Unito 124
IE - Irlanda 90
HK - Hong Kong 79
SE - Svezia 79
FR - Francia 64
VN - Vietnam 57
FI - Finlandia 56
KR - Corea 31
CA - Canada 25
IN - India 14
JP - Giappone 13
UA - Ucraina 13
AR - Argentina 12
NL - Olanda 12
AT - Austria 9
ID - Indonesia 9
TR - Turchia 9
PL - Polonia 8
ZA - Sudafrica 7
BD - Bangladesh 6
BJ - Benin 6
TG - Togo 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ES - Italia 5
AU - Australia 3
EC - Ecuador 3
IQ - Iraq 3
JO - Giordania 3
MX - Messico 3
PY - Paraguay 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
Totale 3.930
Città #
Moscow 302
Dallas 250
Ashburn 197
Singapore 193
Chandler 182
Dublin 90
Southend 86
Hong Kong 79
Munich 57
Beijing 55
Verona 38
Jacksonville 30
New York 26
The Dalles 26
Ho Chi Minh City 25
Los Angeles 25
Turku 25
Helsinki 24
Jinan 24
Woodbridge 22
São Paulo 20
Tianjin 20
Lawrence 19
Princeton 19
Wilmington 17
Houston 16
Rome 16
London 15
Shenyang 15
Milan 14
Taiyuan 14
Columbus 13
Denver 13
Sindelfingen 12
Buffalo 11
Montreal 11
Frankfurt am Main 10
Santa Clara 10
Seattle 10
Tokyo 10
Toronto 10
Ann Arbor 9
Redondo Beach 9
Taizhou 9
Atlanta 8
Seoul 8
Washington 8
Changsha 7
Hanoi 7
Jakarta 7
Kent 7
Monza 7
Redwood City 7
Zhengzhou 7
Chicago 6
Cotonou 6
Fuzhou 6
Haikou 6
Hangzhou 6
Lomé 6
Nanjing 6
Nuremberg 6
Stockholm 6
Warsaw 6
Boston 5
Brussels 5
Guangzhou 5
Hebei 5
Johannesburg 5
Nanchang 5
Orem 5
Phoenix 5
Treviso 5
Amsterdam 4
Bologna 4
Chennai 4
Council Bluffs 4
Fairfield 4
Lancaster 4
Mumbai 4
Ningbo 4
Redmond 4
Rio de Janeiro 4
San Francisco 4
Vienna 4
Amman 3
Boardman 3
Brasília 3
Brescia 3
Brooklyn 3
Falkenstein 3
Frignano 3
Goiânia 3
Jiaxing 3
Lappeenranta 3
Marsala 3
Meda 3
Olomouc 3
Poplar 3
San Jose 3
Totale 2.349
Nome #
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 260
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 222
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 217
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 204
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 202
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 177
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 170
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 166
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 165
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 157
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib 154
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 148
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 147
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 144
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 133
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 130
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 127
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 124
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 119
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 114
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 114
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 102
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 89
Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers 89
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 86
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 85
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 73
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 64
Totale 3.982
Categoria #
all - tutte 14.271
article - articoli 14.271
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 25 0 12 6 1 14 10
2021/2022225 18 83 8 20 3 6 0 13 7 4 12 51
2022/2023498 24 63 36 81 37 137 0 30 63 7 13 7
2023/2024392 7 25 23 48 34 64 62 39 8 25 43 14
2024/2025797 37 32 40 123 37 38 79 37 74 35 108 157
2025/20261.674 135 120 239 407 627 146 0 0 0 0 0 0
Totale 3.982